Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-20

Clinical Trial Update: A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry documents a Phase 3 study comparing Fluticasone furoate 100 mcg once daily with Fluticasone propionate 250 mcg twice daily and Flu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone furoate 100 mcg once daily (Fluticasone furoate)
  • Fluticasone propionate 100 mcg twice daily (Fluticasone propionate)
  • Fluticasone propionate 250 mcg twice daily (Fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-06-20